
Sir Philip Hampton is stepping down from his role as non-executive chairman of British multinational GlaxoSmithKline. The resignation comes just …

The Royal Bank of Scotland’s chairman Sir Philip Hampton has been appointed by GlaxoSmithKline to succeed Sir Christopher Gent in …
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care

